{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:06:10Z","timestamp":1761948370009},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Atypical femoral fractures (AFFs) occur in both osteoporosis patients and cancer patients who receive long-term bisphosphonate treatment. Denosumab offers an alternative approach for the treatment of bone metastases. We describe a 59-year-old woman with a history of breast carcinoma and bone metastasis who was prescribed denosumab for 4 years. The patient had no history of any prior bisphosphonate use. Bone scintigraphy showed an abnormal uptake in the right femur, which was confirmed as an impending AFF or atypical femoral stress reaction. In oncological patients receiving long-term denosumab, AFF should be included as a differential diagnosis for focal femoral findings.<\/jats:p>","DOI":"10.1097\/rlu.0000000000002058","type":"journal-article","created":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T19:52:29Z","timestamp":1520452349000},"page":"365-366","source":"Crossref","is-referenced-by-count":9,"title":["Impending Atypical Femoral Fracture in a Patient of Breast Cancer With Bone Metastases Receiving Long-term Denosumab"],"prefix":"10.1097","volume":"43","author":[{"given":"Tsutomu","family":"Sugihara","sequence":"first","affiliation":[{"name":"From the *Department of Breast Oncology, Yasugi Daiichi Hospital, Shimane; Departments of \u2020Breast Medical Oncology, \u2021Nuclear Medicine, and \u00a7Orthopedic Surgery, Cancer Institute Hospital, Tokyo; and \u2225Department of Gastrointestinal Surgery, Jichi Medical University, Shimotsuke, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Koizumi","sequence":"additional","affiliation":[{"name":"From the *Department of Breast Oncology, Yasugi Daiichi Hospital, Shimane; Departments of \u2020Breast Medical Oncology, \u2021Nuclear Medicine, and \u00a7Orthopedic Surgery, Cancer Institute Hospital, Tokyo; and \u2225Department of Gastrointestinal Surgery, Jichi Medical University, Shimotsuke, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Hayakawa","sequence":"additional","affiliation":[{"name":"From the *Department of Breast Oncology, Yasugi Daiichi Hospital, Shimane; Departments of \u2020Breast Medical Oncology, \u2021Nuclear Medicine, and \u00a7Orthopedic Surgery, Cancer Institute Hospital, Tokyo; and \u2225Department of Gastrointestinal Surgery, Jichi Medical University, Shimotsuke, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Ito","sequence":"additional","affiliation":[{"name":"From the *Department of Breast Oncology, Yasugi Daiichi Hospital, Shimane; Departments of \u2020Breast Medical Oncology, \u2021Nuclear Medicine, and \u00a7Orthopedic Surgery, Cancer Institute Hospital, Tokyo; and \u2225Department of Gastrointestinal Surgery, Jichi Medical University, Shimotsuke, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohiro","family":"Sata","sequence":"additional","affiliation":[{"name":"From the *Department of Breast Oncology, Yasugi Daiichi Hospital, Shimane; Departments of \u2020Breast Medical Oncology, \u2021Nuclear Medicine, and \u00a7Orthopedic Surgery, Cancer Institute Hospital, Tokyo; and \u2225Department of Gastrointestinal Surgery, Jichi Medical University, Shimotsuke, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20231021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1998","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research","volume":"29","year":"2014","journal-title":"J Bone Miner Res"},{"key":"bib2-20231021","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.2106\/JBJS.L.00568","article-title":"Atypical femoral fractures: what do we know about them? AAOS Exhibit Selection","volume":"95","year":"2013","journal-title":"J Bone Joint Surg Am"},{"key":"bib3-20231021","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.4158\/EP12367.CR","article-title":"A case of an unusual subtrochanteric fracture in a patient receiving denosumab","volume":"19","year":"2013","journal-title":"Endocr Pract"},{"key":"bib4-20231021","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bone.2013.12.027","article-title":"Bilateral atypical femoral fractures in a patient prescribed denosumab\u2014a case report","volume":"61","year":"2014","journal-title":"Bone"},{"key":"bib5-20231021","first-page":"249872","article-title":"An atraumatic femoral fracture in a patient with rheumatoid arthritis and osteoporosis treated with denosumab","volume":"2013","year":"2013","journal-title":"Case Rep Rheumatol"},{"key":"bib6-20231021","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/17453674.2013.854668","article-title":"Atypical femoral fractures bilaterally in a patient receiving denosumab","volume":"85","year":"2014","journal-title":"Acta Orthop"},{"key":"bib7-20231021","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3109\/17453674.2014.885355","article-title":"Atypical fracture of the femur in a patient using denosumab\u2014a case report","volume":"85","year":"2014","journal-title":"Acta Orthop"},{"key":"bib8-20231021","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00774-014-0606-6","article-title":"Atypical femoral fracture in a patient treated with denosumab","volume":"33","year":"2015","journal-title":"J Bone Miner Metab"},{"key":"bib9-20231021","first-page":"1","article-title":"Atypical femoral fracture associated with bone-modifying agent for bone metastasis of breast cancer: a report of two cases","volume":"25","year":"2017","journal-title":"J Orthop Surg"},{"key":"bib10-20231021","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/RLU.0000000000001592","article-title":"Impending atypical femoral fracture in patients with medullary thyroid cancer with skeletal metastasis treated with long-term bisphosphonate and denosumab","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib11-20231021","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1634\/theoncologist.2016-0192","article-title":"Retrospective review of atypical femoral fracture in metastatic bone disease patients receiving denosumab therapy","volume":"22","year":"2017","journal-title":"Oncologist"},{"key":"bib12-20231021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/17453674.2013.859423","article-title":"Denosumab and atypical femoral fractures","volume":"85","year":"2014","journal-title":"Acta Orthop"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003072-201805000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T04:52:00Z","timestamp":1697863920000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201805000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002058","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]}}}